In focus · trending topic

Gilead Sciences

2 stories · following the connections

BioNTech Plans Pumitamig-Trodelvy Regimen in Breast Cancer Trial

By Naomi CalderOct 24, 2026, 1:47 AM UTC

BioNTech Plans Trodelvy Combination in Global Phase 3 Breast Cancer Trial

By Naomi CalderOct 22, 2026, 7:35 PM UTC